Follow
Meritxell Pons
Meritxell Pons
Verified email at ub.edu
Title
Cited by
Cited by
Year
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans
R De la Torre, S De Sola, M Pons, A Duchon, MM de Lagran, M Farré, ...
Molecular nutrition & food research 58 (2), 278-288, 2014
3292014
Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease
A di Domenico, G Carola, C Calatayud, M Pons-Espinal, JP Muñoz, ...
Stem cell reports 12 (2), 213-229, 2019
3092019
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 …
R de la Torre, S de Sola, G Hernandez, M Farré, J Pujol, J Rodriguez, ...
The Lancet Neurology 15 (8), 801-810, 2016
2892016
Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling
O Barca-Mayo, M Pons-Espinal, P Follert, A Armirotti, L Berdondini, ...
Nature communications 8 (1), 14336, 2017
1872017
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
JV Sanchez-Mut, H Heyn, E Vidal, S Moran, S Sayols, R Delgado-Morales, ...
Translational psychiatry 6 (1), e718-e718, 2016
1662016
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A
M Pons-Espinal, MM de Lagran, M Dierssen
Neurobiology of disease 60, 18-31, 2013
782013
Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain
M Schouten, P Bielefeld, L Garcia-Corzo, EMJ Passchier, S Gradari, ...
Molecular psychiatry 25 (7), 1382-1405, 2020
602020
Synergic functions of miRNAs determine neuronal fate of adult neural stem cells
M Pons-Espinal, E de Luca, MJ Marzi, R Beckervordersandforth, ...
Stem Cell Reports 8 (4), 1046-1061, 2017
552017
MiR-135a-5p is critical for exercise-induced adult neurogenesis
M Pons-Espinal, C Gasperini, MJ Marzi, C Braccia, A Armirotti, A Pötzsch, ...
Stem Cell Reports 12 (6), 1298-1312, 2019
442019
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
G Carola, D Malagarriga, C Calatayud, M Pons-Espinal, L Blasco-Agell, ...
npj Parkinson's Disease 7 (1), 55, 2021
242021
Functional implications of hippocampal adult neurogenesis in intellectual disabilities
M Pons-Espinal, MM de Lagran, M Dierssen
Amino Acids 45, 113-131, 2013
192013
Environmental enrichment induces epigenomic and genome organization changes relevant for cognition
S Espeso-Gil, AZ Holik, S Bonnin, S Jhanwar, S Chandrasekaran, ...
Frontiers in Molecular Neuroscience 14, 664912, 2021
172021
A new SWATH ion library for mouse adult hippocampal neural stem cells
C Braccia, MP Espinal, M Pini, DDP Tonelli, A Armirotti
Data in Brief 18, 1-8, 2018
172018
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
M Pons-Espinal, L Blasco-Agell, A Consiglio
Cellular and Molecular Life Sciences 78, 2081-2094, 2021
132021
Long-term labeling of hippocampal neural stem cells by a lentiviral vector
H Suh, QG Zhou, I Fernandez-Carasa, GD Clemenson Jr, M Pons-Espinal, ...
Frontiers in Molecular Neuroscience 11, 415, 2018
82018
Piwil2 (Mili) sustains neurogenesis and prevents cellular senescence in the postnatal hippocampus
C Gasperini, K Tuntevski, S Beatini, R Pelizzoli, A Lo Van, D Mangoni, ...
EMBO reports 24 (2), e53801, 2023
62023
The piRNA pathway sustains adult neurogenesis by reducing protein synthesis and cellular senescence
C Gasperini, K Tuntevski, R Pelizzoli, A Lo Van, D Mangoni, RM Cossu, ...
bioRxiv, 2020.09. 15.297739, 2020
52020
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
A Tristán‐Noguero, I Fernández‐Carasa, C Calatayud, ...
EMBO Molecular Medicine 15 (3), e15847, 2023
32023
Immunosuppressive tocilizumab prevents astrocyte induced neurotoxicity in hiPSC-LRRK2 Parkinson’s disease by targeting receptor interleukin-6
M Pons-Espinal, L Blasco-Agell, I Fernandez-Carasa, A di Domenico, ...
bioRxiv, 2022.08. 23.504918, 2022
12022
MiRNA pharmaceutical compositions and therapeutic uses thereof
DDP Tonelli, MP ESPINAL
US Patent 10,792,298, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20